Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Aspire Pharmaceuticals, Inc.
483
•Aspire Pharmaceuticals, Inc.•February 3, 2022

Aspire Pharmaceuticals, Inc. – FDA 483, Feb 3, 2022

Record Details

Aspire Pharmaceuticals, Inc. received a Form 483 citing significant deficiencies across its manufacturing and quality control operations. Issues include inadequate laboratory controls for product specifications and impurity testing, failure to thoroughly investigate out-of-specification results and discrepancies, and poor documentation practices. The firm also lacked proper cleaning validation, test method validation, process validation, and robust quality control procedures for both drug products and dietary supplements, leading to concerns about product identity, strength, quality, and purity.

Company
Aspire Pharmaceuticals, Inc.
Inspection date
February 3, 2022
Product type
drugs
Office
New Jersey District Office
People
  • Annet R. Rajan
  • Laila A. Mathew
  • Charlotte P. Chang
  • Karen A. Spencer
  • Justin A. Boyd (Research Specialist II)
View Company Profile

ID · 5465bf77-219c-4d38-aa04-2a733ccc1ced

Other documents for Aspire Pharmaceuticals, Inc.
  • 483 - 2023-07-14July 14, 2023
  • WARNING_LETTER - 2022-02-03February 3, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Aspire Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.